Expression of the Glioma-Associated Oncogene Homolog 1 (Gli1) in Advanced Serous Ovarian Cancer Is Associated with Unfavorable Overall Survival
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of the Glioma-Associated Oncogene Homolog 1 (Gli1) in Advanced Serous Ovarian Cancer Is Associated with Unfavorable Overall Survival
Authors
Keywords
Ovarian cancer, Hedgehog signaling, Cell proliferation, Multivariate analysis, Paracrine signaling, Cancer treatment, Biotechnology, Polymerase chain reaction
Journal
PLoS One
Volume 8, Issue 3, Pages e60145
Publisher
Public Library of Science (PLoS)
Online
2013-03-29
DOI
10.1371/journal.pone.0060145
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gli family transcription factors are drivers of patupilone resistance in ovarian cancer
- (2012) Simona Mozzetti et al. BIOCHEMICAL PHARMACOLOGY
- Molecular Pathways: The Hedgehog Signaling Pathway in Cancer
- (2012) R. McMillan et al. CLINICAL CANCER RESEARCH
- A Phase II, Randomized, Placebo-Controlled Study of Vismodegib as Maintenance Therapy in Patients with Ovarian Cancer in Second or Third Complete Remission
- (2012) S. B. Kaye et al. CLINICAL CANCER RESEARCH
- Role of Hedgehog Signaling in Malignant Pleural Mesothelioma
- (2012) Y. Shi et al. CLINICAL CANCER RESEARCH
- Intricacies of hedgehog signaling pathways: A perspective in tumorigenesis
- (2012) Swayamsiddha Kar et al. EXPERIMENTAL CELL RESEARCH
- Diindolylmethane-mediated Gli1 Protein Suppression Induces Anoikis in Ovarian Cancer Cellsin Vitroand Blocks Tumor Formation Abilityin Vivo
- (2012) Prabodh K. Kandala et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Smoothened Antagonists Reverse Taxane Resistance in Ovarian Cancer
- (2012) A. D. Steg et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of Gli1 results in altered c-Jun activation, inhibition of cisplatin-induced upregulation of ERCC1, XPD and XRCC1 and inhibition of platinum–DNA adduct repair
- (2012) K Kudo et al. ONCOGENE
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hedgehog signaling pathway as a therapeutic target in various types of cancer
- (2011) Hideya Onishi et al. CANCER SCIENCE
- Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer
- (2011) Ilaria De Stefano et al. GYNECOLOGIC ONCOLOGY
- Targeting Hedgehog -- a Cancer Stem Cell Pathway
- (2010) A. A. Merchant et al. CLINICAL CANCER RESEARCH
- The Epithelial-Mesenchymal Transition and the Estrogen-Signaling in Ovarian Cancer
- (2010) D. Gallo et al. CURRENT DRUG TARGETS
- Expression of Gli1 and PARP1 in medulloblastoma: an immunohistochemical study of 65 cases
- (2010) Joze Pizem et al. JOURNAL OF NEURO-ONCOLOGY
- Limitations of MTT and MTS-Based Assays for Measurement of Antiproliferative Activity of Green Tea Polyphenols
- (2010) Piwen Wang et al. PLoS One
- Context-dependent Regulation of the GLI Code in Cancer by HEDGEHOG and Non-HEDGEHOG Signals
- (2010) B. Stecca et al. Journal of Molecular Cell Biology
- Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
- (2009) Andreas du Bois et al. CANCER
- A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers
- (2009) Barbara Stecca et al. EMBO JOURNAL
- Activation of hedgehog signaling is not a frequent event in ovarian cancers
- (2009) Ling Yang et al. Molecular Cancer
- Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation
- (2008) Xiaoyun Liao et al. CARCINOGENESIS
- Role of Hedgehog Signaling in Ovarian Cancer
- (2008) R. Bhattacharya et al. CLINICAL CANCER RESEARCH
- A paracrine requirement for hedgehog signalling in cancer
- (2008) Robert L. Yauch et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started